Global Prefilled Syringes Drug Market Survey and Trend Research 2018

May 2018 | 76 pages | ID: G949F739321EN
99Strategy

Abstracts

SUMMARY

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Fresenius Kabi AG, Fresenius Kabi AG, Johnson & Johnson, Sanofi, Merck & Co. Inc., Novartis AG etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Prefilled Syringes Drug Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 PREFILLED SYRINGES DRUG MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

PART 4 KEY COMPANIES LIST

4.1 Amgen Inc. (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Teva Pharmaceutical Industries Ltd. (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 AstraZeneca plc (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Mylan N.V. (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Fresenius Kabi AG (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Fresenius Kabi AG (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Johnson & Johnson (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Sanofi (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Merck & Co. Inc. (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Novartis AG (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Prefilled Syringes Drug Market 2012-2017, by Type, in USD Million
Table Global Prefilled Syringes Drug Market 2012-2017, by Type, in Volume
Table Global Prefilled Syringes Drug Market Forecast 2018-2023, by Type, in USD Million
Table Global Prefilled Syringes Drug Market Forecast 2018-2023, by Type, in Volume
Table Amgen Inc. Overview List
Table Prefilled Syringes Drug Business Operation of Amgen Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd. Overview List
Table Prefilled Syringes Drug Business Operation of Teva Pharmaceutical Industries Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca plc Overview List
Table Prefilled Syringes Drug Business Operation of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan N.V. Overview List
Table Prefilled Syringes Drug Business Operation of Mylan N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fresenius Kabi AG Overview List
Table Prefilled Syringes Drug Business Operation of Fresenius Kabi AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fresenius Kabi AG Overview List
Table Prefilled Syringes Drug Business Operation of Fresenius Kabi AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Prefilled Syringes Drug Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Prefilled Syringes Drug Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck & Co. Inc. Overview List
Table Prefilled Syringes Drug Business Operation of Merck & Co. Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Prefilled Syringes Drug Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Prefilled Syringes Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Prefilled Syringes Drug Sales Revenue Share, by Companies, in USD Million
Table Global Prefilled Syringes Drug Sales Volume 2012-2017, by Companies, in Volume
Table Global Prefilled Syringes Drug Sales Revenue Share, by Companies in 2017, in Volume
Table Prefilled Syringes Drug Demand 2012-2017, by Application, in USD Million
Table Prefilled Syringes Drug Demand 2012-2017, by Application, in Volume
Table Prefilled Syringes Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Prefilled Syringes Drug Demand Forecast 2018-2023, by Application, in Volume
Table Global Prefilled Syringes Drug Market 2012-2017, by Region, in USD Million
Table Global Prefilled Syringes Drug Market 2012-2017, by Region, in Volume
Table Prefilled Syringes Drug Market Forecast 2018-2023, by Region, in USD Million
Table Prefilled Syringes Drug Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Prefilled Syringes Drug Industry Chain Structure
Figure Global Prefilled Syringes Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Prefilled Syringes Drug Market Growth 2012-2017, by Type, in Volume
Figure Global Prefilled Syringes Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Prefilled Syringes Drug Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region